200,000+ products from a single source!

sales@angenechem.com

Home > Amines > 101622-51-9

101622-51-9

101622-51-9 | Ethanol, 2-[[9-methyl-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-

CAS No: 101622-51-9 Catalog No: AG0004Z8 MDL No:MFCD00189360

Product Description

Catalog Number:
AG0004Z8
Chemical Name:
Ethanol, 2-[[9-methyl-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-
CAS Number:
101622-51-9
Molecular Formula:
C15H18N6O
Molecular Weight:
298.3430
MDL Number:
MFCD00189360
IUPAC Name:
2-[[6-(benzylamino)-9-methylpurin-2-yl]amino]ethanol
InChI:
InChI=1S/C15H18N6O/c1-21-10-18-12-13(17-9-11-5-3-2-4-6-11)19-15(16-7-8-22)20-14(12)21/h2-6,10,22H,7-9H2,1H3,(H2,16,17,19,20)
InChI Key:
GTVPOLSIJWJJNY-UHFFFAOYSA-N
SMILES:
OCCNc1nc(NCc2ccccc2)c2c(n1)n(C)cn2
UNII:
6A839B2HYS
NSC Number:
666096

Properties

Complexity:
338  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
298.154g/mol
Formal Charge:
0
Heavy Atom Count:
22  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0
Molecular Weight:
298.35g/mol
Monoisotopic Mass:
298.154g/mol
Rotatable Bond Count:
6  
Topological Polar Surface Area:
87.9A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.5  

Literature

Title Journal
Transient inhibition of cell proliferation does not compromise self-renewal of mouse embryonic stem cells. Experimental cell research 20121001
Role of trefoil factor 1 in gastric cancer and relationship between trefoil factor 1 and gastrokine 1. Oncology reports 20121001
Synthesis, biological evaluation, and molecular docking studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline derivatives as novel anticancer agents. Bioorganic & medicinal chemistry 20120815
Co-ordination of cell cycle and differentiation in the developing nervous system. The Biochemical journal 20120615
Hedgehog-mediated regulation of PPARγ controls metabolic patterns in neural precursors and shh-driven medulloblastoma. Acta neuropathologica 20120401
Olomoucine II and purvalanol A inhibit ABCG2 transporter in vitro and in situ and synergistically potentiate cytostatic effect of mitoxantrone. Pharmacological research 20120301
Cdk5 mediates vimentin Ser56 phosphorylation during GTP-induced secretion by neutrophils. Journal of cellular physiology 20120201
Characterization of cyclin E expression in multiple myeloma and its functional role in seliciclib-induced apoptotic cell death. PloS one 20120101
Polydendrocytes display large lineage plasticity following focal cerebral ischemia. PloS one 20120101
[Effect of inhibitors serine/threonine protein kinases and protein phosphatases on mitosis progression of synchronized tobacco by-2 cells]. TSitologiia i genetika 20120101
Design, synthesis and biological study of novel pyrido[2,3-d]pyrimidine as anti-proliferative CDK2 inhibitors. European journal of medicinal chemistry 20111201
In vitro interaction of a novel neutrophil growth factor with human liver microsomal cytochromes P450 and the contribution of UDP-glucuronosyltransferases to its metabolism. Xenobiotica; the fate of foreign compounds in biological systems 20111101
Transcriptional modulation of apoptosis regulators by roscovitine and related compounds. Apoptosis : an international journal on programmed cell death 20110701
Ibulocydine is a novel prodrug Cdk inhibitor that effectively induces apoptosis in hepatocellular carcinoma cells. The Journal of biological chemistry 20110603
Evidence for amylase release by cyclin-dependent kinase 5 in the rat parotid. Archives of biochemistry and biophysics 20110315
Proliferative and androgenic effects of indirubin derivatives in LNCaP human prostate cancer cells at sub-apoptotic concentrations. Chemico-biological interactions 20110201
Reconstitution of human MCF-7 breast cancer cells with caspase-3 does not sensitize them to action of CDK inhibitors. Journal of cellular biochemistry 20110101
Fli+ etsrp+ hemato-vascular progenitor cells proliferate at the lateral plate mesoderm during vasculogenesis in zebrafish. PloS one 20110101
Identification of a phosphorylation-dependent nuclear localization motif in interferon regulatory factor 2 binding protein 2. PloS one 20110101
Striatal signal transduction and drug addiction. Frontiers in neuroanatomy 20110101
Coilin phosphomutants disrupt Cajal body formation, reduce cell proliferation and produce a distinct coilin degradation product. PloS one 20110101
Cyclin-Dependent Kinase 5/p35/p39: A Novel and Imminent Therapeutic Target for Diabetes Mellitus. International journal of endocrinology 20110101
Mitosis-specific phosphorylation of amyloid precursor protein at threonine 668 leads to its altered processing and association with centrosomes. Molecular neurodegeneration 20110101
Predicting the possibility of two newly isolated phenetheren ring containing compounds from Aristolochia manshuriensis as CDK2 inhibitors. Bioinformation 20110101
Functional inactivation of triosephosphate isomerase through phosphorylation during etoposide-induced apoptosis in HeLa cells: potential role of Cdk2. Toxicology 20101205
Comparison of effects of protein kinase A, mitogen-activated protein kinase, and cyclin-dependent kinase blockers on rabbit ovarian granulosa cell functions. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20101201
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
Discovery of novel CDK1 inhibitors by combining pharmacophore modeling, QSAR analysis and in silico screening followed by in vitro bioassay. European journal of medicinal chemistry 20100901
Strong inhibition of replicative DNA synthesis in the developing rat cerebral cortex and glioma cells by roscovitine. Investigational new drugs 20100601
Previous stress exposure enhances both anxiety-like behaviour and p35 levels in the basolateral amygdala complex: modulation by midazolam. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20100601
Cytotoxic activities of several geranyl-substituted flavanones. Journal of natural products 20100423
Phosphorylation of TFIIB links transcription initiation and termination. Current biology : CB 20100323
Design, synthesis, and biological evaluation of novel pyrimidine derivatives as CDK2 inhibitors. European journal of medicinal chemistry 20100301
Cdk2 inhibition prolongs G1 phase progression in mouse embryonic stem cells. Stem cells and development 20100201
Cytochalasin D, LY294002 and olomoucine synergize in promoting death of melanoma cells through activation of caspase-3 and apoptosis. Melanoma research 20100201
Roscovitine increases intracellular calcium release and capacitative calcium entry in PC12 cells. Neuroscience letters 20100118
The inhibitor of cyclin-dependent kinases, olomoucine II, exhibits potent antiviral properties. Antiviral chemistry & chemotherapy 20100105
Synthesis and cytotoxic activity of 2-methylimidazo[1,2-a]pyridine- and quinoline-substituted 2-aminopyrimidine derivatives. European journal of medicinal chemistry 20100101
The radiosensitising effect of olomoucine derived synthetic cyclin-dependent kinase inhibitors. Neoplasma 20100101
Inhibition of human immunodeficiency virus type-1 by cdk inhibitors. AIDS research and therapy 20100101
Key Role of Human ABC Transporter ABCG2 in Photodynamic Therapy and Photodynamic Diagnosis. Advances in pharmacological sciences 20100101
Cell cycle inhibitor enhances the resolution of HSV-1-induced proinflammatory response in murine microglial cells. Neurological research 20091101
MAP kinase dependent cyclinE/cdk2 activity promotes DNA replication in early sea urchin embryos. Developmental biology 20091015
Cyclin-dependent kinase 5 inhibitors: inhibition of dopamine transporter activity. Molecular pharmacology 20091001
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. Nature chemical biology 20091001
The influence of bioactive oxylipins from marine diatoms on invertebrate reproduction and development. Marine drugs 20090901
The D(3) dopamine receptor inhibits dopamine release in PC-12/hD3 cells by autoreceptor signaling via PP-2B, CK1, and Cdk-5. Journal of neurochemistry 20090801
Is olomoucine, a weak CDK2 inhibitor, able to induce apoptosis in cancer cells? Annals of the New York Academy of Sciences 20090801
Interactions of olomoucine II with human liver microsomal cytochromes P450. Drug metabolism and disposition: the biological fate of chemicals 20090601
Functional p53 in cells contributes to the anticancer effect of the cyclin-dependent kinase inhibitor roscovitine. Journal of cellular biochemistry 20090601
Olomoucine inhibits cathepsin L nuclear translocation, activates autophagy and attenuates toxicity of 6-hydroxydopamine. Brain research 20090406
Inhibition of cyclin-dependent kinases by olomoucine and roscovitine reduces lipopolysaccharide-induced inflammatory responses via down-regulation of nuclear factor kappaB. Cell proliferation 20090401
A cell cycle timer for asymmetric spindle positioning. PLoS biology 20090401
The neuronal cell cycle as a mechanism of pathogenesis in Alzheimer's disease. Aging 20090401
Molecular pathology of neuro-AIDS (CNS-HIV). International journal of molecular sciences 20090301
ATP competitive inhibitors of D-alanine-D-alanine ligase based on protein kinase inhibitor scaffolds. Bioorganic & medicinal chemistry 20090201
Cellular phototoxicity evoked through the inhibition of human ABC transporter ABCG2 by cyclin-dependent kinase inhibitors in vitro. Pharmaceutical research 20090201
Crosstalk between Cdk5 and GSK3beta: Implications for Alzheimer's Disease. Frontiers in molecular neuroscience 20090101
Morphogenesis signaling components influence cell cycle regulation by cyclin dependent kinase. Cell division 20090101
CDK5-dependent phosphorylation of the Rho family GTPase TC10(alpha) regulates insulin-stimulated GLUT4 translocation. The Journal of biological chemistry 20081219
Hydrolytic cleavage of N6-substituted adenine derivatives by eukaryotic adenine and adenosine deaminases. Bioscience reports 20081201
Cell cycle-dependent regulation of extra-adrenal glucocorticoid synthesis in murine intestinal epithelial cells. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20081201
Pleiotropic effects of selective CDK inhibitors on human normal and cancer cells. Biochemical pharmacology 20081201
BAX and BAK proteins are required for cyclin-dependent kinase inhibitory drugs to cause apoptosis. Molecular cancer therapeutics 20081201
Distinct functions of Cdk5(Y15) phosphorylation and Cdk5 activity in stress fiber formation and organization. Experimental cell research 20081115
Involvement of septal Cdk5 in the emergence of excessive anxiety induced by stress. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20080801
Rat focal cerebral ischemia induced astrocyte proliferation and delayed neuronal death are attenuated by cyclin-dependent kinase inhibition. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20080301
Cell cycle-specific UNG2 phosphorylations regulate protein turnover, activity and association with RPA. The EMBO journal 20080109
Maize D4;1 and D5 cyclin proteins in germinating maize. Associated kinase activity and regulation by phytohormones. Physiologia plantarum 20080101
The Cdk5 inhibitor olomoucine promotes corneal debridement wound closure in vivo. Molecular vision 20080101
Two specific drugs, BMS-345541 and purvalanol A induce apoptosis of HTLV-1 infected cells through inhibition of the NF-kappaB and cell cycle pathways. AIDS research and therapy 20080101
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases. Proceedings of the National Academy of Sciences of the United States of America 20071218
A new, unexpected action of olomoucine, a CDK inhibitor, on normal human cells: up-regulation of CLIMP-63, a cytoskeleton-linking membrane protein. Journal of cellular biochemistry 20071215
[Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors]. Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme 20071001
[Effects of cyclin dependent protein kinase inhibitor olomoucine on the neuronal apoptosis after status epilepticus: experiment with rats]. Zhonghua yi xue za zhi 20070807
Attenuation of astrogliosis by suppressing of microglial proliferation with the cell cycle inhibitor olomoucine in rat spinal cord injury model. Brain research 20070618
The role of ghrelin and some intracellular mechanisms in controlling the secretory activity of chicken ovarian cells. Comparative biochemistry and physiology. Part A, Molecular & integrative physiology 20070501
Cell cycle inhibition and retinoblastoma protein overexpression prevent Purkinje cell death in organotypic slice cultures. Developmental neurobiology 20070501
Mitotic control of RUNX2 phosphorylation by both CDK1/cyclin B kinase and PP1/PP2A phosphatase in osteoblastic cells. Journal of cellular biochemistry 20070415
Inhibiting cell cycle progression reduces reactive astrogliosis initiated by scratch injury in vitro and by cerebral ischemia in vivo. Glia 20070401
Cell cycle inhibition attenuates microglia induced inflammatory response and alleviates neuronal cell death after spinal cord injury in rats. Brain research 20070302
Phosphorylation of protein phosphatase 1 by cyclin-dependent protein kinase 5 during nerve growth factor-induced PC12 cell differentiation. The Journal of biological chemistry 20070302
Roscovitine regulates invasive breast cancer cell (MDA-MB231) proliferation and survival through cell cycle regulatory protein cdk5. Experimental and molecular pathology 20070201
A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days. British journal of cancer 20070115
A purine analog kinase inhibitor, calcium/calmodulin-dependent protein kinase II inhibitor 59, reveals a role for calcium/calmodulin-dependent protein kinase II in insulin-stimulated glucose transport. Endocrinology 20070101
Acetyl salicylic acid augments functional recovery following sciatic nerve crush in mice. Journal of brachial plexus and peripheral nerve injury 20070101
Spatiotemporal regulation of ATP and Ca2+ dynamics in vertebrate rod and cone ribbon synapses. Molecular vision 20070101
4-arylazo-3,5-diamino-1H-pyrazole CDK inhibitors: SAR study, crystal structure in complex with CDK2, selectivity, and cellular effects. Journal of medicinal chemistry 20061102
Suppression of astroglial scar formation and enhanced axonal regeneration associated with functional recovery in a spinal cord injury rat model by the cell cycle inhibitor olomoucine. Journal of neuroscience research 20061001
p27 small interfering RNA induces cell death through elevating cell cycle activity in cultured cortical neurons: a proof-of-concept study. Cellular and molecular life sciences : CMLS 20061001
Hyperphosphorylation at serine 199/202 of tau factor in the gerbil hippocampus after transient forebrain ischemia. Biochemical and biophysical research communications 20060818
Induction of apoptosis in human lung cancer cells following treatment with amifostine and an adenoviral vector containing wild-type p53. Cancer gene therapy 20060801
Interplay between the p53 tumor suppressor protein family and Cdk5: novel therapeutic approaches for the treatment of neurodegenerative diseases using selective Cdk inhibitors. Molecular neurobiology 20060801
Cyclin dependent kinase inhibitors prevent apoptosis of postmitotic mouse motoneurons. Life sciences 20060627
The effects of presynaptic calcium channel modulation by roscovitine on transmitter release at the adult frog neuromuscular junction. The European journal of neuroscience 20060601
An efficient direct amination of cyclic amides and cyclic ureas. Organic letters 20060525
[Effects of cyclin dependent protein kinase inhibitor olomoucine on the microenvironment of axonal regeneration after spinal cord injury: an experiment with rats]. Zhonghua yi xue za zhi 20060404
The role of protein kinase A and cyclin-dependent (CDC2) kinase in the control of basal and IGF-II-induced proliferation and secretory activity of chicken ovarian cells. Animal reproduction science 20060301
Phosphorylation of RIalpha by cyclin-dependent kinase CDK 2/cyclin E modulates the dissociation of the RIalpha-RFC40 complex. Cell cycle (Georgetown, Tex.) 20060301
Selectivity and potency of cyclin-dependent kinase inhibitors. The AAPS journal 20060301
Analysis on heat stress-induced hyperphosphorylation of stathmin at serine 37 in Jurkat cells by means of two-dimensional gel electrophoresis and tandem mass spectrometry. Journal of chromatography. A 20060217
Zinc(II) complexes with potent cyclin-dependent kinase inhibitors derived from 6-benzylaminopurine: synthesis, characterization, X-ray structures and biological activity. Journal of inorganic biochemistry 20060201
Nitric oxide modulates the expression of cell cycle regulatory genes during lateral root formation in tomato. Journal of experimental botany 20060101
Development and validation of a liquid chromatography/tandem mass spectrometry method for the determination of the novel anticancer agent 17-DMAG in human plasma. Rapid communications in mass spectrometry : RCM 20060101
Cyclin-dependent kinase (CDK) inhibitor olomoucine enhances gamma-irradiation-induced apoptosis and cell cycle arrest in Raji cells. Anticancer research 20060101
Activation of CYP1A1 gene expression during primary culture of mouse hepatocytes. Toxicology 20051215
Molecular models of protein kinase 6 from Plasmodium falciparum. Journal of molecular modeling 20051201
Caspase 8/10 are not mediating apoptosis in neuroblastoma cells treated with CDK inhibitory drugs. European journal of pharmacology 20051107
Pyrazolo[3,4-c]pyridazines as novel and selective inhibitors of cyclin-dependent kinases. Journal of medicinal chemistry 20051103
Cdk2 activity is dispensable for triggering replicon initiation after transient hypoxia in T24 cells. The FEBS journal 20051101
During male pronuclei formation chromatin remodeling is uncoupled from nucleus decondensation. Journal of cellular biochemistry 20051001
Cdk5-dependent regulation of glucose-stimulated insulin secretion. Nature medicine 20051001
Slowed N-type calcium channel (CaV2.2) deactivation by the cyclin-dependent kinase inhibitor roscovitine. Biophysical journal 20050901
Role of the cell cycle in the pathobiology of central nervous system trauma. Cell cycle (Georgetown, Tex.) 20050901
DNA damage induces cdk2 protein levels and histone H2B phosphorylation in SH-SY5Y neuroblastoma cells. Journal of Alzheimer's disease : JAD 20050901
Antiproliferative activity of olomoucine II, a novel 2,6,9-trisubstituted purine cyclin-dependent kinase inhibitor. Cellular and molecular life sciences : CMLS 20050801
In vitro and in vivo pharmacokinetic-pharmacodynamic relationships for the trisubstituted aminopurine cyclin-dependent kinase inhibitors olomoucine, bohemine and CYC202. Clinical cancer research : an official journal of the American Association for Cancer Research 20050701
Signaling pathways in ascidian oocyte maturation: effects of various inhibitors and activators on germinal vesicle breakdown. Development, growth & differentiation 20050501
Resveratrol-induced apoptotic death in human U251 glioma cells. Molecular cancer therapeutics 20050401
Cdk inhibition in human cells compromises chk1 function and activates a DNA damage response. Cancer research 20050201
CIL-102 interacts with microtubule polymerization and causes mitotic arrest following apoptosis in the human prostate cancer PC-3 cell line. The Journal of biological chemistry 20050128
Clinical anticancer drug development: targeting the cyclin-dependent kinases. British journal of cancer 20050117
Phosphorylated amyloid-beta: the toxic intermediate in alzheimer's disease neurodegeneration. Sub-cellular biochemistry 20050101
Farnesyl-transferase inhibitor R115,777 enhances tamoxifen inhibition of MCF-7 cell growth through estrogen receptor dependent and independent pathways. Breast cancer research : BCR 20050101
N-glucosylation of cytokinins by glycosyltransferases of Arabidopsis thaliana. The Journal of biological chemistry 20041112
A three-dimensional in silico pharmacophore model for inhibition of Plasmodium falciparum cyclin-dependent kinases and discovery of different classes of novel Pfmrk specific inhibitors. Journal of medicinal chemistry 20041021
Phosphorylation of Sp1 by cyclin-dependent kinase 2 modulates the role of Sp1 in CTP:phosphocholine cytidylyltransferase alpha regulation during the S phase of the cell cycle. The Journal of biological chemistry 20040917
Mitogen-activated protein kinase regulates neurofilament axonal transport. Journal of cell science 20040915
Cyclin-dependent kinase inhibitors attenuate protein hyperphosphorylation, cytoskeletal lesion formation, and motor defects in Niemann-Pick Type C mice. The American journal of pathology 20040901
Cdk5 regulates activation and localization of Src during corneal epithelial wound closure. Journal of cell science 20040815
Correlation between semaphorin3A-induced facilitation of axonal transport and local activation of a translation initiation factor eukaryotic translation initiation factor 4E. The Journal of neuroscience : the official journal of the Society for Neuroscience 20040707
A novel CDK5-dependent pathway for regulating GSK3 activity and kinesin-driven motility in neurons. The EMBO journal 20040602
Roscovitine, olomoucine, purvalanol: inducers of apoptosis in maturing cerebellar granule neurons. Biochemical pharmacology 20040515
Cell differentiation, caspase inhibition, and macromolecular synthesis blockage, but not BCL-2 or BCL-XL proteins, protect SH-SY5Y cells from apoptosis triggered by two CDK inhibitory drugs. Experimental cell research 20040415
Xylocydine, a novel inhibitor of cyclin-dependent kinases, prevents the tumor necrosis factor-related apoptosis-inducing ligand-induced apoptotic cell death of SK-HEP-1 cells. The Journal of pharmacology and experimental therapeutics 20040301
Development of an assay to screen for inhibitors of tau phosphorylation by cdk5. Journal of biomolecular screening 20040301
Cassette dosing pharmacokinetics of a library of 2,6,9-trisubstituted purine cyclin-dependent kinase 2 inhibitors prepared by parallel synthesis. Molecular cancer therapeutics 20040301
Activation of cyclin-dependent kinase 5 is involved in axonal regeneration. Molecular and cellular neurosciences 20040301
Nuclear translocation of the Hsp70/Hsp90 organizing protein mSTI1 is regulated by cell cycle kinases. Journal of cell science 20040215
Protection of renal cells from cisplatin toxicity by cell cycle inhibitors. American journal of physiology. Renal physiology 20040201
Angiostatin-induced inhibition of endothelial cell proliferation/apoptosis is associated with the down-regulation of cell cycle regulatory protein cdk5. Journal of cellular biochemistry 20040201
Expression profiles of a human pancreatic cancer cell line upon induction of apoptosis search for modulators in cancer therapy. Oncology 20040101
Cell cycle arrest induced in human breast cancer cells by cyclin-dependent kinase inhibitors: a comparison of the effects exerted by roscovitine and olomoucine. Polish journal of pharmacology 20040101
Synergic effects of the cyclin-dependent kinase (CDK) inhibitor olomoucine and androgen-antagonist bicalutamide on prostatic cancer cell lines. Neoplasma 20040101
An inhibition of cyclin-dependent kinases that lengthens, but does not arrest, neuroepithelial cell cycle induces premature neurogenesis. Journal of cell science 20031215
The expression of retinoblastoma and Sp1 is increased by low concentrations of cyclin-dependent kinase inhibitors. European journal of biochemistry 20031201
Changes in the activities of hydroxysteroid dehydrogenases in mouse oocytes during meiotic maturation. The Journal of reproduction and development 20031201
Cdk5/p35 and Rho-kinase mediate ephrin-A5-induced signaling in retinal ganglion cells. Molecular and cellular neurosciences 20031101
Pyrazolo[4,3-d]pyrimidines as new generation of cyclin-dependent kinase inhibitors. Bioorganic & medicinal chemistry letters 20030915
Prevention of dopaminergic neuronal death by cyclic AMP in mixed neuronal/glial mesencephalic cultures requires the repression of presumptive astrocytes. Molecular pharmacology 20030901
Involvement of the transcription factor E2F1/Rb in kainic acid-induced death of murine cerebellar granule cells. Brain research. Molecular brain research 20030819
Cdk2 activity is associated with depolarization of mitochondrial membrane potential during apoptosis. Biochemical and biophysical research communications 20030613
Roscovitine and other purines as kinase inhibitors. From starfish oocytes to clinical trials. Accounts of chemical research 20030601
Synthesis and biological evaluations of pyrazolo[3,4-d]pyrimidines as cyclin-dependent kinase 2 inhibitors. European journal of medicinal chemistry 20030501
The specificities of protein kinase inhibitors: an update. The Biochemical journal 20030401
Mixed ligand complexes of platinum(II) and palladium(II) with cytokinin-derived compounds Bohemine and Olomoucine: X-ray structure of [Pt(BohH+-N7)Cl(3)].9/5H2O [Boh=6-(benzylamino)-2-[(3-(hydroxypropyl)-amino]-9-isopropylpurine, Bohemine]. Journal of inorganic biochemistry 20030401
Studies of the cell cycle of in vitro cultured skin fibroblasts in goats: work in progress. Theriogenology 20030301
Growth cones contain a dynamic population of neurofilament subunits. Cell motility and the cytoskeleton 20030301
Inhibition of nucleoside transport by protein kinase inhibitors. The Journal of pharmacology and experimental therapeutics 20030201
In vitro glycosidation potential towards olomoucine-type cyclin-dependent kinase inhibitors in rodent and primate microsomes. Physiological research 20030101
Activation of the Rb/E2F1 pathway by the nonproliferative p38 MAPK during Fas (APO1/CD95)-mediated neuronal apoptosis. The Journal of biological chemistry 20021213
Synthesis and biological activity of olomoucine II. Bioorganic & medicinal chemistry letters 20021118
Inducible DNA demethylation mediated by the maize Suppressor-mutator transposon-encoded TnpA protein. The Plant cell 20021101
Recent advances in cyclin-dependent kinase inhibition. Purine-based derivatives as anti-cancer agents. Roles and perspectives for the future. Current topics in medicinal chemistry 20020901
PCNA protein associates to Cdk-A type protein kinases in germinating maize. Plant molecular biology 20020901
Association between the cell cycle and neural crest delamination through specific regulation of G1/S transition. Developmental cell 20020901
2,3,7,8-tetrachlorodibenzo-p-dioxin-dependent release from contact inhibition in WB-F344 cells: involvement of cyclin A. Toxicology and applied pharmacology 20020901
M phase-specific expression and phosphorylation-dependent ubiquitination of the ClC-2 channel. The Journal of biological chemistry 20020830
Differential effects of cyclin-dependent kinase blockers upon cell death in the developing retina. Brain research 20020823
Two kinase activities are sufficient for sea urchin sperm chromatin decondensation in vitro. Molecular reproduction and development 20020801
Inhibition of cyclin-dependent kinase 1 by purines and pyrrolo[2,3-d]pyrimidines does not correlate with antiviral activity. Antimicrobial agents and chemotherapy 20020801
Inhibition of mitochondrial permeability transition and release of cytochrome c by anti-apoptotic nucleoside analogues. Biochemical pharmacology 20020801
Synthetic inhibitors of CDKs induce different responses in androgen sensitive and androgen insensitive prostatic cancer cell lines. Molecular pathology : MP 20020801
Mimosine prevents the death of glucose-deprived immunostimulated astrocytes by scavenging peroxynitrite. Glia 20020701
Aspirin provides cyclin-dependent kinase 5-dependent protection against subsequent hypoxia/reoxygenation damage in culture. Journal of neurochemistry 20020701
Molecular mechanism of enhanced apoptotic response in U937 cells mediated by sodium butyrate. Zhonghua zhong liu za zhi [Chinese journal of oncology] 20020701
Structural classification of protein kinases using 3D molecular interaction field analysis of their ligand binding sites: target family landscapes. Journal of medicinal chemistry 20020606
Involvement of cyclin-dependent kinases in axotomy-induced retinal ganglion cell death. The Journal of comparative neurology 20020520
A potential role for AMP-activated protein kinase in meiotic induction in mouse oocytes. Developmental biology 20020501
Phosphorylation and functional regulation of ClC-2 chloride channels expressed in Xenopus oocytes by M cyclin-dependent protein kinase. The Journal of physiology 20020501
Evidence for CRK3 participation in the cell division cycle of Trypanosoma cruzi. Molecular and biochemical parasitology 20020501
Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells. The Journal of biological chemistry 20020419
Beta-carbolines as specific inhibitors of cyclin-dependent kinases. Bioorganic & medicinal chemistry letters 20020408
The amyloid-beta peptide binds to cyclin B1 and increases human cyclin-dependent kinase-1 activity. Neuroscience letters 20020405
Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity. The Journal of neuroscience : the official journal of the Society for Neuroscience 20020401
Kainate receptor-mediated apoptosis in primary cultures of cerebellar granule cells is attenuated by mitogen-activated protein and cyclin-dependent kinase inhibitors. British journal of pharmacology 20020401
Antiproliferative effect of plant cytokinin analogues with an inhibitory activity on cyclin-dependent kinases. Leukemia 20020301
A role for KH domain proteins (Sam68-like mammalian proteins and quaking proteins) in the post-transcriptional regulation of HIV replication. The Journal of biological chemistry 20020222
Sensitivity of the origin decision point to specific inhibitors of cellular signaling and metabolism. Experimental cell research 20020201
Sequential expression patterns of apoptosis- and cell cycle-related proteins in neuronal response to severe or mild transient hypoxia. Neuroscience 20020101
Comparison of the TUNEL, lamin B and annexin V methods for the detection of apoptosis by flow cytometry. Acta histochemica 20020101
The Cdk5-p35 kinase associates with the Golgi apparatus and regulates membrane traffic. EMBO reports 20011215
Sustained activation of p34(cdc2) is required for noscapine-induced apoptosis. The Journal of biological chemistry 20011214
Phosphorylation of amyloid-beta at the serine 26 residue by human cdc2 kinase. Neuroreport 20011204
Cell cycle arrest allows centrin translation but not basal body formation during spermiogenesis in Marsilea. Journal of cell science 20011201
Cell cycle-dependent control of polarised development by a cyclin-dependent kinase-like protein in the Fucus zygote. Development (Cambridge, England) 20011101
Common and reversible regulation of wild-type p53 function and of ribosomal biogenesis by protein kinases in human cells. Oncogene 20010920
Structure-activity relationships and inhibitory effects of various purine derivatives on the in vitro growth of Plasmodium falciparum. Biochemical pharmacology 20010801
Inhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitors. Journal of virology 20010801
Mild cerebral ischemia induces loss of cyclin-dependent kinase inhibitors and activation of cell cycle machinery before delayed neuronal cell death. The Journal of neuroscience : the official journal of the Society for Neuroscience 20010715
Cell death mediated by alloreactive cytotoxic T cells via the granule exocytosis or the Fas pathway is independent of p34cdc2 kinase: Fas dependent killing of cells arrested in the cell cycle. Immunology and cell biology 20010601
Reversible nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase upon serum depletion. European journal of cell biology 20010601
Tetrahydrobiopterin enhances apoptotic PC12 cell death following withdrawal of trophic support. The Journal of biological chemistry 20010323
Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature 20010315
Caspase-mediated Cdk2 activation is a critical step to execute transforming growth factor-beta1-induced apoptosis in human gastric cancer cells. Oncogene 20010308
Cell cycle in the fucus zygote parallels a somatic cell cycle but displays a unique translational regulation of cyclin-dependent kinases. The Plant cell 20010301
Characterization of the Trypanosoma cruzi Cdc2p-related protein kinase 1 and identification of three novel associating cyclins. Molecular and biochemical parasitology 20010301
Modulation of Sp1 activity by a cyclin A/CDK complex. Journal of molecular biology 20010216
The relationship between differentiation and survival in PC12 cells treated with cyclic adenosine monophosphate in the presence of epidermal growth factor or nerve growth factor. Neuroscience letters 20010112
Inhibitory effect of pentalenolactone on vascular smooth muscle cell proliferation. European journal of pharmacology 20010105
Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol. Genome biology 20010101
5-Arylamino-2-methyl-4,7-dioxobenzothiazoles as inhibitors of cyclin-dependent kinase 4 and cytotoxic agents. Bioorganic & medicinal chemistry letters 20000306
2,6,9-trisubstituted purines: optimization towards highly potent and selective CDK1 inhibitors. Bioorganic & medicinal chemistry letters 19990104

© 2019 Angene International Limited. All rights Reserved.